Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 05 Dec 2024

Clonally unrelated HL-type RS manifested as hemophagocytic syndrome: a case report and literature review

in Hematologic Malignancies

Xiaoman Zheng
Wenshuang Ding
Zhigang Zhu
Junping Li
Weijie Zhong

Frontiers in Oncology

doi 10.3389/fonc.2024.1472560

755 views

Case Report

Published on 05 Dec 2024

Case report: HSV lymphadenitis in immunocompromised patient with CLL

in Hematologic Malignancies

Talal Al-Assil
Shane Handelsman
Faisal Ansari
Ellen Flatley
Steven Stone
Mohammad Omaira

Frontiers in Oncology

doi 10.3389/fonc.2024.1401208

1,141 views
1 citation

Clinical Trial

Published on 05 Dec 2024

A 16-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study

in Hematologic Malignancies

Frankie F. Brown
Rebecca Oliver
Rachel Eddy
Adam J. Causer
Annabelle Emery
Harrison D. Collier-Bain
David Dutton
Josephine Crowe
Daniel Augustine
John Graby

Frontiers in Oncology

doi 10.3389/fonc.2024.1472551

2,124 views

Case Report

Published on 05 Dec 2024

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

in Hematologic Malignancies

Danqing Kong
Nana Ping
Qian Zhu
Xiao Zhang
Junhong Li
Rui Zou
Depei Wu
Zhengming Jin
Changju Qu

Frontiers in Oncology

doi 10.3389/fonc.2024.1491100

1,418 views

Case Report

Published on 05 Dec 2024

Case report: Paraganglioma masquerading as angiosarcoma: diagnostic‐dilemma in vascular tumors

in Hematologic Malignancies

Ahilan Raj Rajoo
Saravanan Kannairan
Hisham Arshad Habeebullah Khan
Mohamad Azim Md Idris
Geok Chin Tan
Kishen Raj Chandra Sakaran
Lenny Suryani Safri

Frontiers in Oncology

doi 10.3389/fonc.2024.1462956

598 views

Review

Published on 04 Dec 2024

Updates in novel immunotherapeutic strategies for relapsed/refractory AML

in Hematologic Malignancies

Sawyer Bawek
Sayuri Gurusinghe
Matthew Burwinkel
Amanda Przespolewski

Frontiers in Oncology

doi 10.3389/fonc.2024.1374963

2,091 views

Case Report

Published on 03 Dec 2024

Castleman disease variant of POEMS syndrome without M protein: a case report

in Hematologic Malignancies

Min Ji
Shumin Jin
Shaolei Zang
Peng Li
Fei Lu
Chuanli Zhao
Chunqing Zhang
Chunyan Ji
Jingjing Ye

Frontiers in Oncology

doi 10.3389/fonc.2024.1449945

1,004 views

Case Report

Published on 27 Nov 2024

Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review

in Hematologic Malignancies

Juan Xu
Jie Huang
Liping Xie
Ting Liu
Jianjun Li
Xinchuan Chen
Zhigang Liu
Sha Zhao
Caigang Xu
Yu Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1471090

1,551 views

Case Report

Published on 26 Nov 2024

Case report: Successful use of ruxolitinib to treat interstitial pneumonia as an unusual primary presentation in primary myelofibrosis—two birds with one stone

in Hematologic Malignancies

Pingping Xiao
Zhigao Dong
Qingqing Wang
Junnan Su
Yongquan Chen
Yiwan Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1475036

899 views

Review

Published on 26 Nov 2024

Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement

in Hematologic Malignancies

Guido Lancman
Kevin Song
Darrell White
Tina Crosbie
Ismail Sharif
Marianne Emond
Muhammad Saleem Raza
Martine Elias
Rayan Kaedbey
Michael P. Chu

Frontiers in Oncology

doi 10.3389/fonc.2024.1446995

3,102 views
1 citation

Original Research

Published on 25 Nov 2024

Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacy

in Hematologic Malignancies

Yoganand Balagurunathan
Zhouping Wei
Jin Qi
Zachary Thompson
Erin Dean
Hong Lu
Saran Vardhanabhuti
Salvatore Corallo
Jung W. Choi
Jenny J. Kim

Frontiers in Oncology

doi 10.3389/fonc.2024.1485039

2,174 views

Original Research

Published on 21 Nov 2024

Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma

in Hematologic Malignancies

Gi-June Min
Ye Eun Oh
Youngwoo Jeon
Tong Yoon Kim
Byung-Su Kim
Daehun Kwag
Sung-Soo Park
Silvia Park
Jae-Ho Yoon
Sung-Eun Lee

Frontiers in Oncology

doi 10.3389/fonc.2024.1388623

1,408 views

Original Research

Published on 21 Nov 2024

The characteristics of patients with multiple myeloma surviving over 10 years

in Hematologic Malignancies

Beihui Huang
Hongning Zhang
Junru Liu
Jingli Gu
Meilan Chen
Lifen Kuang
Xiaozhe Li
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1490630

1,296 views

Systematic Review

Published on 20 Nov 2024

Ponatinib vs. asciminib in post–second-generation tyrosine kinase inhibitor therapy for chronic-phase chronic myeloid leukemia: a matching-adjusted indirect comparison

in Hematologic Malignancies

Valentin Garcia-Gutierrez
Fei Huang
Ajibade Ashaye
Mehul Dalal
Victor Laliman-Khara
Massimo Breccia
Megan Rutherford
Hoora Moradian
Petros Patos
Elias Joseph Jabbour

Frontiers in Oncology

doi 10.3389/fonc.2024.1455378

3,039 views
1 citation

Case Report

Published on 14 Nov 2024

Hemangiopericytoma following allogeneic hematopoietic stem cell transplantation in a patient with primary plasma cell leukemia: the first case report and literature review

in Hematologic Malignancies

Yajun Shi
Guohao Liang
Haiying Zhang
Yaqing Wang
Ying Han
Shenglian Tong
Shunyu Liang
Ying Wang
Hai Bai

Frontiers in Oncology

doi 10.3389/fonc.2024.1467237

710 views

Mini Review

Published on 04 Nov 2024

Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma

in Hematologic Malignancies

Oliver Tomkins

Frontiers in Oncology

doi 10.3389/fonc.2024.1490202

2,611 views
1 citation